Dr. Sarika Wairkar, Associate Professor at SVKM’s NMIMS Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management (popularly known as SPPSPTM), has recently been granted the Indian patent No. 408059 for her research work titled- ‘Topical Foam Composition Comprising Mupirocin’.
Her invention is related to the foam formulation of Mupirocin - a commonly used topical antibiotic in traumatic skin lesions and burn wounds. Currently, Mupirocin is commercially available as a cream formulation which needs to be applied by touching the skin or wound surface.
Dr. Sarika Wairkar from SPPSPTM has prepared Mupirocin foam for topical application with quick collapse time, good spreadability, and superior antibacterial efficacy. It can be easily applied to the desired area without touching the wound. After the successful conduct of clinical trials, it has been established that this formulation can be used as an alternative to the conventional topical dosage form.
Furthermore, Dr Sarika Wairkar, Associate Professor, SPPSPTM, NMIMS, has clarified that this formulation was designed considering severe pain and infection of critical wounds, especially burn wounds where the application of medicine is a difficult task. As a result, this formulation may substantially help in the management of chronic wounds.
On this occasion, the Dean of SPPSPTM, Dr Bala Prabhakar spoke about the school’s continued thrust on ground-breaking research. For people unversed, SPPSPTM was established under the aegis of SVKM’s NMIMS in 2006 as a pharmacy school, offering doctoral, postgraduate, graduate and diploma programmes in pharmaceutical sciences. The school is a pioneer in introducing integrated programmes in pharmacy and technology management.
Mohali (Punjab)
Indore (Madhya Pradesh)
Nashik (Maharashtra)
Mohali (Punjab)
Coimbatore (Tamil Nadu)
Andhra Pradesh D Pharmacy admission date 2025: DPharma is a two-year pharmacy diploma programme. To be eligible for admission to the D Pharma course, candidates must have at least 50% aggregate marks in Physics, Chemistry, and Biology as compulsory subjects. Department of Technical Education, AP is responsible for conducting DPharm admissions in Andhra Pradesh. The admissions are done through a state-level entrance examination. Admissions to this course usually begin in August - September. Department of Technical Education releases the merit list, the basis of which, the counselling process to select candidates is completed. Those looking forward to applying to DPharm admission in Andhra Pradesh can read the article below to know about the admission schedule, eligibility, selection, counselling, and top colleges.
Also Read: D.Pharmacy Admission 2025 in India
Andhra B.Pharma Admission 2025: As per the official notification published by the Andhra Pradesh State Council of Higher Education (APSCHE) dated February 13, the AP EAMCET/ EAPCET Pharmacy 2025 exam will be conducted on May 19 & 20, 2025, by Jawaharlal Nehru Technological University, Kakinada. The official portal @cets.apsche.ap.gov.in is now accepting applications for the AP EAPCET 2025 registration from March 15, 2025 onwards. Examinees may apply for AP EAMCET 2025 until April 24, 2025, without incurring a late fee; additional deadlines for late application submissions are set for May 16, 2025.
Andhra B.Pharma admission 2025 is done based on the marks secured by the candidates in the AP EAMCET 2025 exam. It is a state-level exam for admissions to Agriculture, Engineering, and Pharmacy courses offered at more than 425 private institutes in the state, however, the exam dates differ based on the stream. The AP EAMCET 2025 eligibility criteria include passing higher secondary exams with Physics, Chemistry, Biology, or Mathematics as subjects and securing a minimum of 50% aggregate marks. Students can apply for Andhra B Pharmacy admission 2025 by submitting their AP Intern 2nd Year result 2025. As per the AP EAMCET 2025 exam pattern, the exam will be conducted in online mode. A total of 160 multiple-choice questions will be asked of the students. Read below to learn more about the Andhra B.Pharma Admission 2025, application, syllabus, exam pattern, and important dates.
CUET B Pharm syllabus 2025: The purpose of the CUET B Pharma entrance exam syllabus 2025 is to assess applicants' proficiency in academic areas such as chemistry, biology, physics, mathematics, and English. The National Testing Agency (NTA) will publish the B Pharm syllabus for CUET UG 2025 on its official portal. The NTA's official brochure provides students with further details regarding the B Pharma CUET syllabus 2025. To perform extremely well on the test, students must be familiar with the CUET B Pharmacy syllabus 2025. Alcohols, Phenols, and Ethers; Biotechnology and its Applications; Electromagnetic Induction and Alternating Currents; and Reproduction are a few of the key topics covered in the CUET syllabus for B Pharma.
The GPAT exam is conducted for M.Pharma admissions in top medical institutes in India. The GPAT is a 3-hour long online test and the competition is intense! Only around 10% of those who apply for the GPAT exam successfully clear it every year.
The GPAT exam is expected to take place in June 2025, and as the exam date approaches, students should focus on achieving a score of 300+ and earning a top ten rank in the merit list.
To score 300 in GPAT, you need to understand the syllabus well and practice the previous year's papers. Focus on key topics and take regular mock tests. Manage your time effectively and prioritize basic concepts along with advanced knowledge. Be aware of negative markings. In short, create a thorough study plan that emphasizes practice and analysis.
All AICTE/PCI-approved institutions in India accept the GPAT scores. There are about 24,000 M. Pharm admission seats available through GPAT, with over 841 pharmacy colleges and universities participating. Since 2018, the National Board of Examinations in Medical Sciences (NBMES) conducts the GPAT exam.
Keep reading to know more about How to Score 300+ in GPAT, and the Factors Affecting a Good Score in GPAT.